SEC 13F Intelligence

Hussman Strategic Advisors, Inc. / TGTX

Hussman Strategic Advisors, Inc.’s Tg Therapeutics Inc Position

Does Hussman Strategic Advisors, Inc. own Tg Therapeutics Inc (TGTX)? Not currently — the last reported position was 126.0K shares worth $5M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$5M
Q3 2025
Shares
126.0K
% of Portfolio
+0.99%
Quarters Held
6
position exited

Position History TGTX

Reported value by quarter
Q3 ’23: $438,900Q3 ’23Q3 ’24: $2MQ3 ’24Q4 ’24: $1MQ4 ’24Q1 ’25: $2MQ1 ’25Q2 ’25: $5MQ2 ’25Q3 ’25: $5MQ3 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2025126.0K$5M+0.99%
Q2 2025126.0K$5M+1.04%
Q1 202552.5K$2M+0.50%
Q4 202442.0K$1M+0.37%
Q3 2024105.0K$2M+0.60%
Q3 202352.5K$438,900+0.08%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Hussman Strategic Advisors, Inc.’s full portfolio or all institutional holders of TGTX.